![]() |
NEW MEXICO | 300 Oak Street NE Albuquerque, NM 87106 |
|||||||||||||||||||||||||||
CLINICAL RESEARCH & OSTEOPOROSIS CENTER |
Phone: 505-855-5525 Fax: 505-884-4006 |
||||||||||||||||||||||||||||
| -------------------E. Michael Lewiecki, MD, FACP, FACE - Osteoporosis Director -|- Lance A. Rudolph, MD - Research Director | |||||||||||||||||||||||||||||
|
Our Current Osteoporosis StudiesA Silent Dangerous DiseaseOsteoporosis is sometimes called the “silent thief.” It is a serious disease that weakens the bones, making them fragile. In time, bones may break causing pain, deformity, and some-times severe disability. Osteopenia is the early form of the disease indicated by low bone mineral density. Any kind of fracture may occur, but the most common are fractures of the spine, hip, and wrist. Osteoporosis is not an iinevitable part of aging, but is a disease that can be prevented and treated, provided it is detected early. Why Should I Participate in a Clinical Trial? As a volunteer in a clinical research trial you will not only take on an active role in your own health care but you will also:
Whatever reason you chose to participate in clinical research, be assured that you are engaging in the advancement of medical treatments, therapies, and cures for chronic or life-threatening diseases. We are currently enrolling in three unique studies follow these links to fine out more
E. Michael Lewiecki, MD This page update 12/22/09
|
|
|||||||||||||||||||||||||||